Caris Life Sciences, Inc. (CAI)
19.29
+0.16
(+0.84%)
USD |
NASDAQ |
Apr 02, 16:00
19.28
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences Profit Margin (Quarterly) : 27.98% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 19.08% |
| Glaukos Corp. | -93.39% |
| Edgewise Therapeutics, Inc. | -- |
| Nuvalent, Inc. | -- |
| Alphatec Holdings, Inc. | -10.20% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -38.79% |
| Return on Assets | -9.20% |
| Return on Invested Capital | -11.37% |
| Gross Profit Margin (Quarterly) | 75.43% |
| Operating Margin (Quarterly) | 30.19% |
| Return on Net Operating Assets | -29.41% |